Skip to content
Search

Latest Stories

UK vaccine roll-out to be slower than hoped, deliveries to pick up from May

The government said on Thursday that due to lumps and bumps in the global supply chain, vaccine roll-out in the country would be slower than hoped in coming weeks but deliveries will increase again in May, June and July.

Health officials warned on Wednesday that the world’s fastest big economy roll-out of the vaccine would face a significant reduction in supplies from March 29.


Pfizer Inc and AstraZeneca Plc said their delivery schedules had not been impacted, and Housing Secretary Robert Jenrick refused to be drawn on whether the issue was due to a problem with supply from India.

“We have less supply than we might have hoped for the coming weeks but we expect it to increase again later,” Jenrick told the BBC.

“The vaccine roll-out will be slightly slower than we might have hoped but not slower than the target,” he said. “We have every reason to believe that supply will increase in the months of May, June and July.”

Britain is on track to have given a first Covid-19 shot to half of all adults in the next few days, making it one of the fastest countries to roll out a vaccine.

So far 25.27 million people in the United Kingdom have had a vaccine, around 48 per cent of adults.

“We always said right from the beginning that a new manufacturing process would have its lumps and bumps and that has been the case in the past and I’m sure it will be in the future,” Jenrick told Sky.

“We’re sourcing vaccines from all over the world and we are experiencing occasionally some issues and that’s led to this, this issue with some supply in the coming weeks,” he said.

Asked if the issue was supply from India, Jenrick declined to discuss specific contracts.

He said Britain remained on track to have vaccinated priority groups by April 15 and all adults by the end of July.

The European Union threatened on Wednesday to ban exports of Covid-19 vaccines to Britain to safeguard scarce doses for its own citizens facing a third wave of the pandemic that would jeopardise plans to restart travel this summer.

The threat from European Commission head Ursula von der Leyen was disappointing, Jenrick said.

“I was surprised and disappointed by those comments but the prime minister had spoken earlier in the year to Ursula von der Leyen and she gave a very clear commitment, which was that the EU would not engage in this sort of activity, that contractual responsibilities would be honoured.

“And that’s exactly what we intend to do and I hope and expect the EU to stick to their side of the bargain.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less